ES2436037T3 - Spray nasal o gotas nasales para el tratamiento del resfriado común - Google Patents

Spray nasal o gotas nasales para el tratamiento del resfriado común Download PDF

Info

Publication number
ES2436037T3
ES2436037T3 ES09721305T ES09721305T ES2436037T3 ES 2436037 T3 ES2436037 T3 ES 2436037T3 ES 09721305 T ES09721305 T ES 09721305T ES 09721305 T ES09721305 T ES 09721305T ES 2436037 T3 ES2436037 T3 ES 2436037T3
Authority
ES
Spain
Prior art keywords
hydrogen peroxide
nasal
common cold
oxidase
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES09721305T
Other languages
English (en)
Spanish (es)
Inventor
Krister Tano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2436037T3 publication Critical patent/ES2436037T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES09721305T 2008-03-20 2009-03-20 Spray nasal o gotas nasales para el tratamiento del resfriado común Active ES2436037T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0800658 2008-03-20
SE0800658 2008-03-20
PCT/SE2009/050291 WO2009116944A1 (en) 2008-03-20 2009-03-20 Use of a substance for manufacturing of a medicament for treatment of common cold

Publications (1)

Publication Number Publication Date
ES2436037T3 true ES2436037T3 (es) 2013-12-26

Family

ID=41091160

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09721305T Active ES2436037T3 (es) 2008-03-20 2009-03-20 Spray nasal o gotas nasales para el tratamiento del resfriado común

Country Status (8)

Country Link
US (1) US8895282B2 (enExample)
EP (1) EP2276505B1 (enExample)
JP (1) JP5558458B2 (enExample)
CN (1) CN101977625A (enExample)
DK (1) DK2276505T3 (enExample)
ES (1) ES2436037T3 (enExample)
PL (1) PL2276505T3 (enExample)
WO (1) WO2009116944A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3245871A1 (en) 2014-04-30 2017-11-22 Matoke Holdings Limited Antimicrobial compositions
US10213491B2 (en) * 2015-05-19 2019-02-26 The Penn State Research Foundation Glucose oxidase compositions as a neonate anticonvulsant
US20180280483A1 (en) * 2015-08-21 2018-10-04 Morinaga Milk Industry Co., Ltd. Agent for protecting upper respiratory tract and food or drink composition for protecting upper respiratory tract
CA3038590A1 (en) * 2016-10-06 2018-04-12 Matoke Holdings Limited Antimicrobial compositions
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions
CN112105378B (zh) 2018-01-03 2025-03-11 宾夕法尼亚州研究基金会 作为新生儿抗惊厥药的葡萄糖氧化酶组合物
CN112351766A (zh) 2018-06-25 2021-02-09 璀昂芬制药公司 使用含锌的组合物抑制微生物感染的方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8702831L (sv) 1987-07-10 1989-01-11 Ewos Ab Microbicid komposition
GB9002422D0 (en) 1990-02-03 1990-04-04 Boots Co Plc Anti-microbial compositions
WO1992014484A1 (en) 1991-02-21 1992-09-03 Exoxemis, Inc. Methods and compositions for the treatment of infection and control of flora
US5389369A (en) 1991-02-21 1995-02-14 Exoxemis, Inc. Halo peroxidase containing compositions for killing yeast and sporular microorganisms
GB2285218A (en) * 1993-12-17 1995-07-05 William Elwyn Roberts An aid to recovery from disease caused by bacteria fungi viruses and malignant cells
GB9406075D0 (en) 1994-03-26 1994-05-18 Boots Co Plc Method of killing microorganisms
SE506529C2 (sv) 1996-01-23 1997-12-22 Semper Ab Användning av ett laktoperoxidassystem för framställning av ett läkemedel mot Helicobacter pylori
CO4910145A1 (es) 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
WO1999002148A1 (en) * 1997-07-11 1999-01-21 The Johns Hopkins University School Of Medicine Nitric oxide inhibits rhinovirus infection
DE29723959U1 (de) 1997-07-22 1999-07-22 Zellner, Gerhard, Dr., 83435 Bad Reichenhall Nasenspray-Flüssigkeit
AU7584500A (en) 1999-09-17 2001-04-17 Smithkline Beecham Corporation Use of csaids in rhinovirus infection
US20040033260A1 (en) * 1999-10-19 2004-02-19 The Procter & Gamble Company Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc
US6214339B1 (en) 2000-01-12 2001-04-10 Michael A. Pellico Di-enzymatic treatment of outer ear infection in dogs and cats
AR030753A1 (es) 2000-09-25 2003-09-03 Smithkline Beecham Corp Uso de moduladores-proteina de il-8, groalfa, grobeta, grogamma, nap-2, y ena-78, para tratar infecciones viricas
SE0200876L (sv) 2002-03-22 2003-09-23 Krister Tano Nässpray mot öroninflammationer
CN1408358A (zh) * 2002-09-20 2003-04-09 高艺歌 一种葡萄糖酸锌(胶体)喷鼻剂的处方组成
US7968122B2 (en) * 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions
WO2005113026A2 (en) 2004-04-22 2005-12-01 Medical Discoveries, Inc. Method of treating respiratory disorders and airway inflammation
US20070026085A1 (en) 2005-07-26 2007-02-01 Global Life Technologies Corp. Antimicrobial and antiviral composition
BRPI0617481A2 (pt) 2005-10-21 2011-07-26 Danisco composiÇço que compreende um sistema enzimÁtico acoplado

Also Published As

Publication number Publication date
JP5558458B2 (ja) 2014-07-23
EP2276505B1 (en) 2013-09-18
JP2011515391A (ja) 2011-05-19
DK2276505T3 (da) 2013-11-25
EP2276505A1 (en) 2011-01-26
US8895282B2 (en) 2014-11-25
EP2276505A4 (en) 2011-06-22
CN101977625A (zh) 2011-02-16
PL2276505T3 (pl) 2014-01-31
US20110044966A1 (en) 2011-02-24
WO2009116944A1 (en) 2009-09-24

Similar Documents

Publication Publication Date Title
ES2436037T3 (es) Spray nasal o gotas nasales para el tratamiento del resfriado común
ES2949139T3 (es) Composición que elimina la congestión nasal y que tiene actividad antivírica
ES2340363T3 (es) Metodo y composicion para el tratamiento de la neuropatia diabetica.
ES2394344T3 (es) Uso de lactoferrina bovina para el tratamiento de inflamación destructiva de membranas mucosas
KR20170009276A (ko) 호흡기 바이러스성 질환 치료를 위한 라도티닙의 용도
ES2426783T3 (es) Extracto acuoso de Ribes para el tratamiento de infecciones virales
US20240261313A1 (en) Kit for preventing or treating filovirus and flavivirus diseases
ES2860098T3 (es) Composición para la aplicación nasal
CN111388421A (zh) 一种具有抗菌和抗病毒功能的口鼻喉双组分喷剂及制备方法
ES2981451T3 (es) Composición farmacéutica antiviral que comprende al menos un polisacárido sulfatado
WO2013147585A1 (en) A composition having antiviral activity against flavivirus
WO2021191904A1 (en) Methods for preventing and treating viral infection
WO2022078563A1 (en) A new mixed compound for treatment and protection from covid-19 (corona) virus
ES2313281T3 (es) Composicion farmaceutica que comprende alcohol 2,4-diclorbencilico y amilmetacresol.
US8357720B2 (en) Treatment or prevention of cancer and precancerous disorders
ES2919882T3 (es) Sustancia para la profilaxis y el tratamiento de infecciones por virus de la influenza
CN111991414B (zh) 一种β-壳糖胺在制备预防和治疗新冠肺炎病毒感染的药物中的用途
CN114288307A (zh) 一种含唾液酸盐的产品及其应用
Go et al. Intranasal therapy and COVID-19: A comprehensive literature review
ES2856553T3 (es) Composiciones que comprenden dihidroquercetina para uso en métodos para el tratamiento del herpes
ES2989089T3 (es) Composición farmacéutica para uso en el tratamiento de enfermedad inducida por virus
CN107648249A (zh) 去半乳糖替告皂甙在制备防治流感病毒感染的药物中的应用
WO2022157540A1 (es) Producto para la piel con prolongado efecto residual profiláctico contra el contagio de covid-19
Rajak et al. Molecular Insights into Anti-SARS-CoV-2 Activity of Catechins against Protein Targets for COVID-19 Management
Barati et al. Minireview Highlight article